发明名称 Azetidine Derivatives
摘要 Compounds of formula (I) are inhibitors of fatty acid amide hydrolase, (FAAH), and which are useful in the treatment of diseases or medical conditions which benefit from inhibition of FAAH activity, such as anxiety, depression pain, inflammation, and eating, sleep, neurodegenerative and movement disorders:;;Wherein Ar1 is optionally substituted phenyl or optionally substituted monocyclic heteroaryl having 5 or 6 ring atoms; Ar2 is optionally substituted phenyl, optionally substituted monocyclic heteroaryl having 5 or 6 ring atoms or optionally substituted fused bicyclic heteroaryl having 5 or 6 ring atoms in each fused ring; and Ar3 is a divalent radical selected from the group consisting of optionally substituted phenylene and optionally substituted monocyclic heteroarylene radicals having 5 or 6 ring atoms.
申请公布号 US2015183769(A1) 申请公布日期 2015.07.02
申请号 US201514641783 申请日期 2015.03.09
申请人 Vernalis (R&D) Ltd. 发明人 Roughley Stephen;Walls Steven;Hart Terance;Parsons Rachel;Brough Paul;Graham Christopher;Macias Alba
分类号 C07D413/14;C07D401/12;C07D401/14;C07D205/04 主分类号 C07D413/14
代理机构 代理人
主权项 1. A method of treatment of a disease or medical condition which benefits from inhibition of FAAH activity, comprising administering to a subject suffering such disease or condition an effective amount of a compound of formula (I), or a pharmaceutically acceptable salt thereof: wherein Ar1 is optionally substituted phenyl or optionally substituted monocyclic heteroaN having 5 or 6 ring atoms; Ar2 is optionally substituted phenyl, optionally substituted monocyclic heteroaryl having 5 or 6 ring atoms or optionally substituted fused bicyclic heteroaryl having 5 or 6 ring atoms in each fused ring; and Ar3 is a divalent radical selected from the group consisting of optionally substituted phenylene and optionally substituted monocyclic heteroarylene radicals having 5 or 6 ring atoms.
地址 Winnersh GB